These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 12210444

  • 1. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors.
    Stern JW, Bunin N.
    Med Pediatr Oncol; 2002 Sep; 39(3):163-7. PubMed ID: 12210444
    [Abstract] [Full Text] [Related]

  • 2. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B, Pediatric Oncology Group 9048, Children's Cancer Group 8891.
    J Clin Oncol; 2004 Sep 01; 22(17):3563-9. PubMed ID: 15337806
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL.
    J Clin Oncol; 2004 Mar 01; 22(5):846-53. PubMed ID: 14990640
    [Abstract] [Full Text] [Related]

  • 5. Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
    Pectasides D, Skarlos D, Dimopoulos AM, Farmakis D, Pectasides M, Fountzilas G, Aravantinos G.
    Anticancer Res; 2003 Mar 01; 23(5b):4239-44. PubMed ID: 14666633
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
    Dimopoulos MA, Papadopoulou M, Andreopoulou E, Papadimitriou C, Pavlidis N, Aravantinos G, Aspropotamitis A, Anagnostopoulos A, Fountzilas G, Michalas S, Pectacides D.
    Gynecol Oncol; 1998 Jul 01; 70(1):70-4. PubMed ID: 9698477
    [Abstract] [Full Text] [Related]

  • 8. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA.
    Cancer J Sci Am; 1998 Jul 01; 4(2):110-24. PubMed ID: 9532413
    [Abstract] [Full Text] [Related]

  • 9. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U.
    Klin Padiatr; 1993 Jul 01; 205(4):231-40. PubMed ID: 7690864
    [Abstract] [Full Text] [Related]

  • 10. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A, Biron P, Philip I, Blay JY, Droz JP.
    Bull Cancer; 1999 Apr 01; 86(4):391-9. PubMed ID: 10341344
    [Abstract] [Full Text] [Related]

  • 11. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Apr 01; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 12. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
    Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, Gray E, McKeever P, Hale J, Bailey S, Oakhill A.
    J Clin Oncol; 2000 Nov 15; 18(22):3809-18. PubMed ID: 11078494
    [Abstract] [Full Text] [Related]

  • 13. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE.
    J Urol; 1999 Apr 15; 161(4):1148-52. PubMed ID: 10081858
    [Abstract] [Full Text] [Related]

  • 14. Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors: a randomized comparison.
    Bosl GJ, Bajorin DF.
    Semin Oncol; 1994 Oct 15; 21(5 Suppl 12):61-4. PubMed ID: 7992068
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
    Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D, Siegert W.
    Cancer; 1997 Jan 01; 79(1):161-8. PubMed ID: 8988741
    [Abstract] [Full Text] [Related]

  • 17. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I, Miyake H, Yamada Y, Yamanaka K, Furukawa J, Kumano M, Takenaka A, Fujisawa M.
    Anticancer Drugs; 2006 Oct 01; 17(9):1057-66. PubMed ID: 17001179
    [Abstract] [Full Text] [Related]

  • 18. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec 01; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 19. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W.
    Bone Marrow Transplant; 1997 Nov 01; 20(10):813-9. PubMed ID: 9404920
    [Abstract] [Full Text] [Related]

  • 20. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT.
    Obstet Gynecol; 1996 Apr 01; 87(4):527-31. PubMed ID: 8602303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.